Suchergebnisse - "Bulusu, Krishna C"

PubPharm (29)

1

Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations

enthalten in: Cancer discovery | 2024

von Bashi, A. | Coker, E. | Bulusu, K. | +34

2

Network-driven cancer cell avatars for combination discovery and biomarker identification for DNA Damage Response inhibitors

enthalten in: bioRxiv.org | 2023

von Papp, O. | Jordán, V. | Hetey, S. | +11

3

Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Gray, J. | Ahn, M. | Oxnard, G. | +19

4

Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial

enthalten in: Nature communications | 2023

von Chmielecki, J. | Mok, T. | Wu, Y. | +13

5

Comparison of classical tumour growth models for patient derived and cell-line derived xenografts using the nonlinear mixed-effects framework

enthalten in: Journal of biological dynamics | 2022

von Voulgarelis, D. | Bulusu, K. | Yates, J.

6

Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Serra, V. | Wang, A. | Castroviejo-Bermejo, M. | +37

7

Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer

enthalten in: Nature communications | 2022

von Gogleva, A. | Polychronopoulos, D. | Pfeifer, M. | +12

8

A cancer pharmacogenomic screen powering crowd-sourced advancement of drug combination prediction

enthalten in: bioRxiv.org | 2021

von Menden, M. | Wang, D. | Guan, Y. | +23

9

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

enthalten in: Nature communications | 2019

von Menden, M. | Wang, D. | Mason, M. | +124

10

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

enthalten in: Nature Communications | Jun 17 2019

von Menden, M. | Wang, D. | Mason, M. | +23